These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation. Kamath S; Blann AD; Chin BS; Lip GY J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115 [TBL] [Abstract][Full Text] [Related]
23. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy. Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781 [TBL] [Abstract][Full Text] [Related]
24. Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus? Tayebjee MH; Lip GY Am J Cardiol; 2003 Jul; 92(1):47-9. PubMed ID: 12842244 [No Abstract] [Full Text] [Related]
25. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis. Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020 [TBL] [Abstract][Full Text] [Related]
26. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study]. Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220 [TBL] [Abstract][Full Text] [Related]
27. Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation. Skov J; Sidelmann JJ; Bladbjerg EM; Jespersen J; Gram J Thromb Res; 2014 Sep; 134(3):717-22. PubMed ID: 25042725 [TBL] [Abstract][Full Text] [Related]
28. Should patients with lone atrial fibrillation be treated with anticoagulant therapy. Lui CY J Am Coll Cardiol; 1991 Jul; 18(1):301-2. PubMed ID: 2050934 [No Abstract] [Full Text] [Related]
29. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. Yamamoto R; Nakae Y; Tanaka F; Johkura K J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270 [TBL] [Abstract][Full Text] [Related]
30. [Predictive value of D-dimer assay in superficial thrombophlebitis of the lower limbs]. Gillet JL; Ffrench P; Hanss M; Allaert FA; Chleir F J Mal Vasc; 2007 Apr; 32(2):90-5. PubMed ID: 17379463 [TBL] [Abstract][Full Text] [Related]
31. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation. Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514 [TBL] [Abstract][Full Text] [Related]
32. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation? Zeuthen EL; Lassen JF; Husted SE Thromb Res; 2003 Mar; 109(5-6):241-6. PubMed ID: 12818245 [TBL] [Abstract][Full Text] [Related]
33. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462 [TBL] [Abstract][Full Text] [Related]
34. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299 [TBL] [Abstract][Full Text] [Related]
35. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation. Krarup LH; Sandset EC; Sandset PM; Berge E Acta Neurol Scand; 2011 Jul; 124(1):40-4. PubMed ID: 20726843 [TBL] [Abstract][Full Text] [Related]
36. Appropriate Use of Venous Imaging and Analysis of the D-Dimer/Clinical Probability Testing Paradigm in the Diagnosis and Location of Deep Venous Thrombosis. Mousa AY; Broce M; De Wit D; Baskharoun M; Abu-Halimah S; Yacoub M; Bates MC Ann Vasc Surg; 2018 Jul; 50():21-29. PubMed ID: 29501900 [TBL] [Abstract][Full Text] [Related]
37. Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation. Hall A; Simpson RFG; Mitchell ARJ Cardiovasc Hematol Disord Drug Targets; 2017; 17(1):58-63. PubMed ID: 28056733 [TBL] [Abstract][Full Text] [Related]
38. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Somlói M; Tomcsányi J; Nagy E; Bodó I; Bezzegh A Am J Cardiol; 2003 Jul; 92(1):85-7. PubMed ID: 12842257 [No Abstract] [Full Text] [Related]
39. Serum potassium levels inversely correlate with D-dimer in patients with acute-onset atrial fibrillation. Cervellin G; Bonfanti L; Picanza A; Lippi G Arq Bras Cardiol; 2015 Mar; 104(3):181-4. PubMed ID: 25884769 [TBL] [Abstract][Full Text] [Related]
40. Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients. Nakatani Y; Mizumaki K; Nishida K; Hirai T; Sakabe M; Oda Y; Joho S; Fujiki A; Nozawa T; Inoue H Circ J; 2012; 76(2):317-21. PubMed ID: 22185714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]